IMP2-IN-2
IMP2-IN-2 (compound 6) is a potent and selective IMP2 inhibitor, with IC50s of 120.9 μM and 236.7 μM for IMP2 interaction with RNA_A and RNA_B, respectively. IMP2-IN-2 can be used for the research of cancer[1].
Product Specifications
CAS Number
1448353-39-6
UNSPSC
12352005
Target
Insulin Receptor
Type
Reference compound
Related Pathways
Protein Tyrosine Kinase/RTK
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/imp2-in-2.html
Concentration
10mM
Purity
99.93
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
O=C(C1=C(NC(N(CC)CC2=CC=CC=C2)=O)C=C(C3=CC=C(C(F)(F)F)C=C3)S1)O
Molecular Formula
C22H19F3N2O3S
Molecular Weight
448.46
References & Citations
[1]Dahlem C, et, al. First Small-Molecule Inhibitors Targeting the RNA-Binding Protein IGF2BP2/IMP2 for Cancer Therapy. ACS Chem Biol. 2022 Feb 18;17 (2) :361-375.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
![Mouse Monoclonal DPP9 Antibody (OTI2E3) [PerCP]](https://cdn.genprice.uk/genprice/uk/genprice4.webp)
NBP2-72318PCP 0.1 mL
Mouse Monoclonal DPP9 Antibody (OTI2E3) [PerCP]
Sign In for Pricing
View Details 
215282 100 µL
Endothelin B Receptor (ETrB, EDNRB, ETBR, ET-B, ET-BR, Endothelin Receptor Non-selective Type, ETRB)
Sign In for Pricing
View Details 
